Medline Inc. Excess of Replacement or Current Costs over Stated LIFO Value
Medline Inc. (MDLN) had Excess of Replacement or Current Costs over Stated LIFO Value of $391.00 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Inventory › LIFO Method Related Items
us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue · last filed 2026-08-05
- 2026-06-27: Excess of Replacement or Current Costs over Stated LIFO Value $391.00M.
- 2026-03-28: Excess of Replacement or Current Costs over Stated LIFO Value $388.00M.
- 2025-12-31: Excess of Replacement or Current Costs over Stated LIFO Value $359.00M.
- 2024-12-31: Excess of Replacement or Current Costs over Stated LIFO Value $276.00M.
| Period end | Excess of Replacement or Current Costs over Stated LIFO Value |
|---|---|
| 2026-06-27 | $391.00M 10-Q · filed 2026-08-05 |
| 2026-03-28 | $388.00M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $359.00M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $276.00M 10-K · filed 2026-02-25 |